COVID19 – From SAMHSA: Tips For Social Distancing, Quarantine, And Isolation During An Infectious Disease Outbreak 

The Caring Ambassadors Lung Cancer Program provides this website to help you and your loved ones understand your disease and some of the health care options available to you.
Knowledge empowers you to ask the necessary questions to become your own best advocate.

The Caring Ambassadors Hepatitis C Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
We are honored to serve the community to help eliminate the largest infectious disease outbreak of our time

MY CHOICES© is a tool to help you recognize and act upon what you can control in your health care journey to achieve optimal healing, regardless of the illness you face. It contains elements of a guide book, health planner, journal, and activity book to help orient you to and plan for the journey ahead.

AmazonSmile is a website operate by Amazon with the same products, prices and shopping features as Amazon.com. The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products. 

The time is now. 71 million people worldwide are living with chronic Hepatitis C right now. It is the largest chronic infectious disease outbreak of our time…and it’s curable. Talk to your doctor about treatment for your Hepatitis C, and don’t take no for an answer

Weekly News Update.
Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.

My Choices© Update
Week Ending March 30, 2020

How This Integrative Medicine Doctor Is Staying Healthy Right Now
“Fears about COVID-19 combined with social isolation can lead to high levels of anxiety. So how can we maintain both our mental and physical health during these uncertain times? According to integrative medicine doctor Amy Shah, M.D., spending time in nature can help. “

COVID-19: Tips for mindfulness and coping with anxiety
“Anxiety is not right, and it is not wrong. It is just part of the human experience,” says Kristin Lothman, a mind-body counselor with Mayo Clinic’s Department of Integrative Medicine and Health. “Healthy anxiety calls us into action to be safe, to take care of the people that we love and to arrive at the present moment experience with resilience.”

Using cannabinoids to treat acute pain
“A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain.”

Nike offers workout app for free as COVID-19 keeps people indoors
“Without mentioning “coronavirus” by name, Nike is offering its workout and health content for free as millions of people seek ways to maintain their exercise and diet regimens during the COVID-19 crisis.”

Hepatitis C News
Week Ending March 30, 2020

Epclusa Approved for Pediatric Patients with Chronic Hepatitis C Infection
“The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Epclusa® (sofosbuvir/velpatasvir; Gilead Sciences) for the treatment of pediatric patients aged ≥6 years weighing at least 17kg with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis; or in combination with ribavirin in those with decompensated cirrhosis. Previously, the combination therapy had only been approved for adults.”

Liver Cancer Increase Driven Mainly by NASH in Men Over 60
“Liver cancer rates have been increasing, but a new analysis finds that the increase has occurred primarily in men older than 60 years in developed countries.”

Updated guidelines recommend all adults screen for hepatitis C, regardless of risk
“The US Preventive Services Task Force (USPSTF) recently released new guidelines, in early March, for the screening of hepatitis C virus infections, last updated in 2013.”

A micro-elimination approach to addressing hepatitis C in Turkey
“In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study reports new national prevalence data, breaks it down by subpopulation, and models scenarios to reach HCV elimination.”

Risk for Hepatitis C Virus High Among PWID and Share Needles
“People who inject drugs (PWID) and participate in receptive needle sharing (RNS) are vulnerable to higher infectivity rates for hepatitis C virus infection, according to a paper published in Open Forum Infectious Diseases.”

New hepatitis C cases down by almost 70% in HIV positive men
“New cases of hepatitis C among HIV positive men in London and Brighton have fallen by nearly 70% in recent years, according to researchers, whose findings have now sparked a change in guidelines.”

Practice Pearl 1: Different Ways Hepatitis C Virus is Transmitted
“Hepatitis C specialists identify the different ways hepatitis C virus can be transmitted.”

Risk Model for Hepatocellular Carcinoma Among Chronic HCV Patients
“A newly developed hepatocellular carcinoma (HCC) risk score enables risk stratification for HCC development among patients with chronic hepatitis C (HCV) infections at sustained virologic response, according to data published in the European Journal of Gastroenterology & Hepatology.”

Lung Cancer News
Week Ending March 30, 2020

The IASLC is collecting member and patient experiences with COVID-19 as a way to pool knowledge and connect our members during this public health crisis. These stories, information from the Journal of Thoracic Oncology (JTO), and official statements from the IASLC will be published on this page. In addition, this page will feature links to important resources such as journal articles and social media groups relevant to the care of patients with lung cancer.

Coronavirus and Lung Cancer: Crucial Coronavirus (Covid-19) information on Hope With Answers: Living With Lung Cancer podcasts
“Los Angeles, CA, March 27, 2020 (GLOBE NEWSWIRE) — Covid-19 caused by the Coronavirus poses a significant risk to people living with lung cancer and people who are immunocompromised. Lung Cancer Foundation of America is stepping in to help with podcasts featuring the latest research and information from lung cancer experts and patients telling their stories during the pandemic.”

Are Patients with Cancer at Higher Risk of COVID-19?
“Patients with cancer who are diagnosed with the novel coronavirus (COVID-19) tend to have poorer outcomes, and it is vital that the oncology treatment team screen their patients for the virus before continuing on with treatment, according to a small study conducted in Wuhan, China.”

AI-powered blood test detects lung cancer with DNA analysis
“Stanford researchers have developed a way to screen for lung cancer by combining next-gen molecular DNA quantification with machine learning. The experimental technique requires only a blood test and could, with refinement, replace low-dose CT scanning as an initial exam for longtime smokers.”

Delaying Cancer Surgery During COVID-19
“Cancer surgeries may need to be delayed as hospitals are forced to allocate resources to a surge of COVID-19 patients, says the American College of Surgeons, as it issues a new set of recommendations in reaction to the crisis.”

FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer
“The FDA has approved durvalumab (Imfinzi) in combination with standard-of-care chemotherapy, etoposide and carboplatin or cisplatin, as a frontline treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC).1

Can a blood test pinpoint lung cancers in high-risk people?
“It’s not really news that elderly people with a significant smoking history are at increased risk for lung cancers. Annual, low-dose computed tomography scans for those at especially high risk have been shown to be a useful way to catch the disease early enough to reduce deaths. But this type of screening has a high false-discovery rate, and only about 5% of eligible patients actually choose or have access to regular CT scans.”